Cargando…

Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study

In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Francesco, Riezzo, Giuseppe, Linsalata, Michele, Orlando, Antonella, Tutino, Valeria, Prospero, Laura, D'Attoma, Benedetta, Giannelli, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886127/
https://www.ncbi.nlm.nih.gov/pubmed/35242794
http://dx.doi.org/10.3389/fnut.2022.797192
_version_ 1784660584272232448
author Russo, Francesco
Riezzo, Giuseppe
Linsalata, Michele
Orlando, Antonella
Tutino, Valeria
Prospero, Laura
D'Attoma, Benedetta
Giannelli, Gianluigi
author_facet Russo, Francesco
Riezzo, Giuseppe
Linsalata, Michele
Orlando, Antonella
Tutino, Valeria
Prospero, Laura
D'Attoma, Benedetta
Giannelli, Gianluigi
author_sort Russo, Francesco
collection PubMed
description In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a cereal of Spanish origin derived from the hybridization of durum wheat and wild barley. It is different from classic wheat for its gluten protein composition, with fewer carbohydrates and fructans and a higher content of proteins, dietary fibers, and antioxidants. This pilot study aimed to investigate the effects of a 12-week diet with Tritordeum-based foods in substitution of other cereals on the profile of GI symptoms (evaluated by appropriate questionnaire) and the health of the GI barrier (assessed by sugar absorption test and different markers of integrity and functions) in 16 diarrhea-predominant IBS (IBS-D) patients. The diet with Tritordeum-based foods (bread, bakery products, and pasta) significantly reduced IBS-D patients' symptoms. This amelioration appears to occur through an overall improvement of the GI barrier, as demonstrated by the reduced intestinal permeability and the decreased levels of markers of intestinal mucosal integrity, mucosal inflammation, and fermentative dysbiosis.
format Online
Article
Text
id pubmed-8886127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88861272022-03-02 Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study Russo, Francesco Riezzo, Giuseppe Linsalata, Michele Orlando, Antonella Tutino, Valeria Prospero, Laura D'Attoma, Benedetta Giannelli, Gianluigi Front Nutr Nutrition In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a cereal of Spanish origin derived from the hybridization of durum wheat and wild barley. It is different from classic wheat for its gluten protein composition, with fewer carbohydrates and fructans and a higher content of proteins, dietary fibers, and antioxidants. This pilot study aimed to investigate the effects of a 12-week diet with Tritordeum-based foods in substitution of other cereals on the profile of GI symptoms (evaluated by appropriate questionnaire) and the health of the GI barrier (assessed by sugar absorption test and different markers of integrity and functions) in 16 diarrhea-predominant IBS (IBS-D) patients. The diet with Tritordeum-based foods (bread, bakery products, and pasta) significantly reduced IBS-D patients' symptoms. This amelioration appears to occur through an overall improvement of the GI barrier, as demonstrated by the reduced intestinal permeability and the decreased levels of markers of intestinal mucosal integrity, mucosal inflammation, and fermentative dysbiosis. Frontiers Media S.A. 2022-02-15 /pmc/articles/PMC8886127/ /pubmed/35242794 http://dx.doi.org/10.3389/fnut.2022.797192 Text en Copyright © 2022 Russo, Riezzo, Linsalata, Orlando, Tutino, Prospero, D'Attoma and Giannelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Russo, Francesco
Riezzo, Giuseppe
Linsalata, Michele
Orlando, Antonella
Tutino, Valeria
Prospero, Laura
D'Attoma, Benedetta
Giannelli, Gianluigi
Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title_full Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title_fullStr Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title_full_unstemmed Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title_short Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
title_sort managing symptom profile of ibs-d patients with tritordeum-based foods: results from a pilot study
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886127/
https://www.ncbi.nlm.nih.gov/pubmed/35242794
http://dx.doi.org/10.3389/fnut.2022.797192
work_keys_str_mv AT russofrancesco managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT riezzogiuseppe managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT linsalatamichele managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT orlandoantonella managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT tutinovaleria managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT prosperolaura managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT dattomabenedetta managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy
AT giannelligianluigi managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy